WHAT IS THE AIM OF THE REGULATION?
Regulation (EU) 2026/1388 sets out specific rules for plants obtained by certain new genomic techniques (NGTs) and their products. It aims at protecting human and animal health and the environment, while supporting innovation, sustainability, competitiveness and the effective functioning of the European Union (EU) internal market.
KEY POINTS
Scope
The regulation covers plants obtained by targeted mutagenesis1, cisgenesis2 or a combination of the two. Such plants are called NGT plants. The regulation applies to:
- NGT plants;
- food and feed that contain, consist of or are produced from NGT plants;
- other products that contain or consist of NGT plants, such as seeds and other plant reproductive material or forest reproductive material.
The regulation does not cover animals, microorganisms or fungi, or plants containing genetic material from species that cannot be crossed through conventional breeding. These remain subject to the existing EU rules on genetically modified organisms (GMOs), in particular Directive 2001/18/EC (see summary) and Regulation (EC) No 1829/2003 (see summary).
Two categories of NGT plants
The regulation distinguishes between:
- category 1 NGT plants, the modifications of which could occur naturally or through conventional breeding;
- category 2 NGT plants, covering all other NGT plants.
To qualify as category 1, an NGT plant must fulfil two conditions:
- it must meet the criteria of equivalence to conventional plants in Annex I; and
- its genetic modifications must not be intended to convey herbicide tolerance or the production of a known insecticidal substance.
Category 1 NGT plants
Category 1 NGT plants and products are not subject to the EU rules on GMOs, and are therefore subject to the legislation for conventionally bred plants and products. A formal decision confirming category 1 status is required before release or marketing (verification procedure). Under this regime:
- the decision applies throughout the EU to the category 1 NGT plant and its products;
- different procedural pathways apply depending on whether the decision is requested before experimental releases in the EU, or, in the absence of such, before the plant or its products are placed on the market;
- the requester provides scientific evidence on the technique, modifications, equivalence criteria and intended traits, together with available patent information, although patents do not affect eligibility;
- the European Commission maintains a public database of these decisions;
- plant and forest reproductive material must be labelled ‘NGT-1’, followed by the relevant identification number or numbers, which also appear in variety catalogues and marketing documents.
Category 2 NGT plants
Category 2 NGT plants and products remain subject to the EU rules on GMOs, with certain adaptations. They require:
- authorisations, both before field trials or other non-market releases and before marketing, based on the principles of GMO risk assessment but adapted to the level of risk;
- sampling and detection methods, with adapted requirements in case of technical limitations;
- GMO traceability and labelling, with the option to indicate voluntarily the traits conveyed by the modifications;
- post-market environmental monitoring, unless a duly justified exemption is accepted.
After the first renewal, an authorisation is normally valid for an unlimited period, unless a limited period is justified.
The possibility for EU Member States to restrict or prohibit the cultivation of GMOs on their territory and to take appropriate measures to avoid the unintended presence of GMOs in other products also continues to apply.
Category 2 NGT plants with traits relevant for sustainability listed in Annex IV can benefit from regulatory incentives.
Organic production
Neither plant category may be used in organic production. The adventitious or technically unavoidable presence of category 1 NGT plants or products produced from or by them does not by itself breach EU organic production rules.
Patent-related measures
The regulation requires requesters to provide information on patents on category 1 NGT plants and enables requesters to submit licensing declarations for these patents. The regulation also requires the Commission to develop guidance on plant intellectual property matters, oversee the drawing up of a voluntary EU-level code of conduct, including commitments by patent owners and licensing platforms, and assess the impacts of NGT plant patenting. The Commission is to be assisted by an NGT plant patent expert group.
Monitoring of implementation and controls
The Commission monitors the implementation of the regulation and the health, environmental, economic and social impacts of NGT plants and products under the new regime. Member States organise controls and must stop any unauthorised release or marketing. The regulation also amends Regulation (EU) 2017/625 (see summary) to align certain cross references with the new regulation.
FROM WHEN DOES THE REGULATION APPLY?
The regulation will apply from 17 July 2028. Some rules on guidance and patent-related measures have applied since 16 July 2026.
BACKGROUND
For further information, see:
KEY TERMS
- Targeted mutagenesis. Techniques that make one or more DNA changes at specific locations in an organism’s genome.
- Cisgenesis. Techniques that insert genetic material from species that can be crossed with the target organism through conventional breeding. In the regulation, the term includes intragenesis, which is the insertion of a rearranged copy of that genetic material.
MAIN DOCUMENT
Regulation (EU) 2026/1388 of the European Parliament and of the Council of 17 June 2026 on plants obtained by certain new genomic techniques and their products, and amending Regulation (EU) 2017/625 (OJ L, 2026/1388, 26.6.2026).
RELATED DOCUMENTS
Directive 2001/18/EC on the deliberate release into the environment of GMOs.
Successive amendments to Directive 2001/18/EC have been incorporated into the original text. This consolidated version is of documentary value only.
Regulation (EC) No 1829/2003 on genetically modified food and feed.
See consolidated version.